NCT00442117View on ClinicalTrials.gov

A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)

PHASE3CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Asthma

Interventions

DRUG

mometasone furoate dry powder inhaler

MF DPI 200 mcg, two puffs once daily PM (total of 400 mcg/day) for 12 weeks.

DRUG

Budesonide DPI

Budesonide (BUD) DPI 200 mcg, two puffs twice daily (total of 800 mcg/day) for 12 weeks.

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00442117 - A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880) | Biotech Hunter | Biotech Hunter